FDA FAERS Reports for Korlym (mifepristone) from Jan 1, 2024 to Present

FDA FAERS Reports for Korlym (mifepristone) from Jan 1, 2024 to Present

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: All FDA FAERS reports for Korlym (mifepristone) during the period of January 1, 2024 to present.
Tags: Pharma, FAERS, 2024
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

View full details